Amanda Watts v. Medicis Pharmaceutical Corporation

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• adopting the learned intermediary doctrine as set forth in Restatement (Third) of Torts: Prod. Liab. § 6(d) as to prescription drug manufacturers and holding that a manufacturer satisfies its duty to warn end users by giving appropriate warnings to learned intermediaries
• “the doctrine provides a means by which a manufacturer may satisfy its duty to warn the end user.”
• a defendant may be held liable for failure to warn “based on informational defects encompassing instructions and warnings that render a product defective and unreasonably dangerous” (citation and quotation marks omitted)
• “[T]he [Arizona Consumer Fraud Act] applies to prescription pharmaceuticals.”
• adopting the Restatement (Third) 5 of Torts § 6(d)
• adopting the Restatement (Third) of Torts § 6(d)

Source: CourtListener parenthetical corpus (CC0).